Human Ventricular Stem Cell Cardiomyocytes: Validating In Vitro Assays and Screening Platforms for Pro-arrhythmia Risk Prediction

Marc Rogers; John Ridley; Said El-Haou; Sarah Williams; Louise Webdale; Kathy Sutton; Sonja Stoelzle-Feix; Ulrich Thomas; Niels Fertig; Tom Zwetsloot; Harsha D. Devalla; Robert Passier

doi:10.1016/j.vascn.2017.09.238

Human Ventricular Stem Cell Cardiomyocytes: Validating In Vitro Assays and Screening Platforms for Pro-arrhythmia Risk Prediction

Marc Rogers, John Ridley, Said El-Haou, Sarah Williams, Louise Webdale, Kathy Sutton, Sonja Stoelzle-Feix, Ulrich Thomas, Niels Fertig, Tom Zwetsloot, Harsha D. Devalla, Robert Passier

Applied Stem Cell Technologies

Research output: Contribution to journal › Meeting Abstract › Other research output

Original language	English
Article number	0237
Pages (from-to)	241-241
Journal	Journal of Pharmacological and Toxicological Methods
Volume	88
Issue number	2
DOIs	https://doi.org/10.1016/j.vascn.2017.09.238
Publication status	Published - 2017

Access to Document

10.1016/j.vascn.2017.09.238

Cite this

Rogers, M., Ridley, J., El-Haou, S., Williams, S., Webdale, L., Sutton, K., Stoelzle-Feix, S., Thomas, U., Fertig, N., Zwetsloot, T., Devalla, H. D., & Passier, R. (2017). Human Ventricular Stem Cell Cardiomyocytes: Validating In Vitro Assays and Screening Platforms for Pro-arrhythmia Risk Prediction. Journal of Pharmacological and Toxicological Methods, 88(2), 241-241. [0237]. https://doi.org/10.1016/j.vascn.2017.09.238

@article{e98a16d94e174aed858fce10eeb6a971,

title = "Human Ventricular Stem Cell Cardiomyocytes: Validating In Vitro Assays and Screening Platforms for Pro-arrhythmia Risk Prediction",

author = "Marc Rogers and John Ridley and Said El-Haou and Sarah Williams and Louise Webdale and Kathy Sutton and Sonja Stoelzle-Feix and Ulrich Thomas and Niels Fertig and Tom Zwetsloot and Devalla, {Harsha D.} and Robert Passier",

year = "2017",

doi = "10.1016/j.vascn.2017.09.238",

language = "English",

volume = "88",

pages = "241--241",

journal = "Journal of Pharmacological and Toxicological Methods",

issn = "1056-8719",

publisher = "Elsevier",

number = "2",

}

Rogers, M, Ridley, J, El-Haou, S, Williams, S, Webdale, L, Sutton, K, Stoelzle-Feix, S, Thomas, U, Fertig, N, Zwetsloot, T, Devalla, HD & Passier, R 2017, 'Human Ventricular Stem Cell Cardiomyocytes: Validating In Vitro Assays and Screening Platforms for Pro-arrhythmia Risk Prediction', Journal of Pharmacological and Toxicological Methods, vol. 88, no. 2, 0237, pp. 241-241. https://doi.org/10.1016/j.vascn.2017.09.238

TY - JOUR

T1 - Human Ventricular Stem Cell Cardiomyocytes: Validating In Vitro Assays and Screening Platforms for Pro-arrhythmia Risk Prediction

AU - Rogers, Marc

AU - Ridley, John

AU - El-Haou, Said

AU - Williams, Sarah

AU - Webdale, Louise

AU - Sutton, Kathy

AU - Stoelzle-Feix, Sonja

AU - Thomas, Ulrich

AU - Fertig, Niels

AU - Zwetsloot, Tom

AU - Devalla, Harsha D.

AU - Passier, Robert

PY - 2017

Y1 - 2017

U2 - 10.1016/j.vascn.2017.09.238

DO - 10.1016/j.vascn.2017.09.238

M3 - Meeting Abstract

VL - 88

SP - 241

EP - 241

JO - Journal of Pharmacological and Toxicological Methods

JF - Journal of Pharmacological and Toxicological Methods

SN - 1056-8719

IS - 2

M1 - 0237

ER -